Lurine A. Vaughan

1.8k total citations
20 papers, 1.6k citations indexed

About

Lurine A. Vaughan is a scholar working on Pulmonary and Respiratory Medicine, Biomedical Engineering and Molecular Biology. According to data from OpenAlex, Lurine A. Vaughan has authored 20 papers receiving a total of 1.6k indexed citations (citations by other indexed papers that have themselves been cited), including 19 papers in Pulmonary and Respiratory Medicine, 16 papers in Biomedical Engineering and 5 papers in Molecular Biology. Recurrent topics in Lurine A. Vaughan's work include Photodynamic Therapy Research Studies (19 papers), Nanoplatforms for cancer theranostics (16 papers) and Porphyrin and Phthalocyanine Chemistry (5 papers). Lurine A. Vaughan is often cited by papers focused on Photodynamic Therapy Research Studies (19 papers), Nanoplatforms for cancer theranostics (16 papers) and Porphyrin and Phthalocyanine Chemistry (5 papers). Lurine A. Vaughan collaborates with scholars based in United States. Lurine A. Vaughan's co-authors include Barbara W. Henderson, Sandra O. Gollnick, David A. Bellnier, William R. Greco, Barbara Owczarczak, Heinz Baumann, Thomas J. Dougherty, Patricia Maier, John W. Snyder and Sharon S. Evans and has published in prestigious journals such as Clinical Cancer Research, Journal of Medicinal Chemistry and British Journal of Cancer.

In The Last Decade

Lurine A. Vaughan

20 papers receiving 1.5k citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
Lurine A. Vaughan United States	16	1.2k	1.1k	339	249	241	20	1.6k
Gürcan Günaydın Türkiye	15	730 0.6×	998 0.9×	571 1.7×	375 1.5×	193 0.8×	27	1.7k
Lina Bezdetnaya France	28	1.3k 1.1×	1.3k 1.2×	617 1.8×	403 1.6×	142 0.6×	73	1.8k
Aisling O’Connor Ireland	12	845 0.7×	802 0.7×	708 2.1×	382 1.5×	171 0.7×	18	1.6k
Mustafa Emre Gedik Türkiye	9	514 0.4×	681 0.6×	337 1.0×	236 0.9×	113 0.5×	17	1.1k
JV Moore United Kingdom	14	566 0.5×	426 0.4×	158 0.5×	170 0.7×	86 0.4×	22	951
Arnold Mittleman United States	6	941 0.8×	524 0.5×	321 0.9×	298 1.2×	98 0.4×	10	1.3k
Antonio R. Antunez United States	10	545 0.5×	387 0.3×	221 0.7×	196 0.8×	105 0.4×	19	777
Marie‐Ange D’Hallewin Belgium	22	863 0.7×	771 0.7×	220 0.6×	229 0.9×	87 0.4×	43	1.3k
Marian E. Clay United States	8	569 0.5×	411 0.4×	240 0.7×	231 0.9×	108 0.4×	12	735
Adnan O. Abu‐Yousif United States	15	330 0.3×	487 0.4×	81 0.2×	268 1.1×	95 0.4×	35	1.1k

Countries citing papers authored by Lurine A. Vaughan

Since Specialization

Citations

This map shows the geographic impact of Lurine A. Vaughan's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Lurine A. Vaughan with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Lurine A. Vaughan more than expected).

Fields of papers citing papers by Lurine A. Vaughan

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Lurine A. Vaughan. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Lurine A. Vaughan. The network helps show where Lurine A. Vaughan may publish in the future.

Co-authorship network of co-authors of Lurine A. Vaughan

This figure shows the co-authorship network connecting the top 25 collaborators of Lurine A. Vaughan. A scholar is included among the top collaborators of Lurine A. Vaughan based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Lurine A. Vaughan. Lurine A. Vaughan is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

Seshadri, Mukund, David A. Bellnier, Lurine A. Vaughan, et al.. (2008). Light Delivery over Extended Time Periods Enhances the Effectiveness of Photodynamic Therapy. Clinical Cancer Research. 14(9). 2796–2805. 62 indexed citations

Kabingu, Edith, Lurine A. Vaughan, Barbara Owczarczak, Kimberley D. Ramsey, & Sandra O. Gollnick. (2007). CD8+ T cell-mediated control of distant tumours following local photodynamic therapy is independent of CD4+ T cells and dependent on natural killer cells. British Journal of Cancer. 96(12). 1839–1848. 112 indexed citations

Henderson, Barbara W., Erin Tracy, Lurine A. Vaughan, et al.. (2007). Cross-Linking of Signal Transducer and Activator of Transcription 3—A Molecular Marker for the Photodynamic Reaction in Cells and Tumors. Clinical Cancer Research. 13(11). 3156–3163. 32 indexed citations

Gollnick, Sandra O., Sharon S. Evans, Heinz Baumann, et al.. (2003). Role of cytokines in photodynamic therapy-induced local and systemic inflammation. British Journal of Cancer. 88(11). 1772–1779. 292 indexed citations

Snyder, John W., William R. Greco, David A. Bellnier, Lurine A. Vaughan, & Barbara W. Henderson. (2003). Photodynamic therapy: a means to enhanced drug delivery to tumors.. PubMed. 63(23). 8126–31. 161 indexed citations

Gollnick, Sandra O., Lurine A. Vaughan, & Barbara W. Henderson. (2002). Generation of effective antitumor vaccines using photodynamic therapy.. PubMed. 62(6). 1604–8. 205 indexed citations

Dougherty, Thomas J., Adam B. Sumlin, William R. Greco, et al.. (2002). The Role of the Peripheral Benzodiazepine Receptor in Photodynamic Activity of Certain Pyropheophorbide Ether Photosensitizers: Albumin Site II as a Surrogate Marker for Activity¶. Photochemistry and Photobiology. 76(1). 91–91. 23 indexed citations

Gollnick, Sandra O., et al.. (2001). Activation of the IL-10 Gene Promoter Following Photodynamic Therapy of Murine Keratinocytes¶. Photochemistry and Photobiology. 73(2). 170–170. 25 indexed citations

Gollnick, Sandra O., David A. Musser, Allan R. Oseroff, et al.. (2001). IL-10 Does not Play a Role in Cutaneous Photofrin® Photodynamic Therapy-induced Suppression of the Contact Hypersensitivity Response¶. Photochemistry and Photobiology. 74(6). 811–811. 23 indexed citations

10.

Gollnick, Sandra O., et al.. (2001). Photodynamic therapy (PDT) treatment enhances tumor cell antigenicity. Proceedings of SPIE, the International Society for Optical Engineering/Proceedings of SPIE. 4257. 25–25. 4 indexed citations

11.

Chen, Yihui, Andrew E. Graham, William R. Potter, et al.. (2001). Bacteriopurpurinimides: Highly Stable and Potent Photosensitizers for Photodynamic Therapy. Journal of Medicinal Chemistry. 45(2). 255–258. 63 indexed citations

12.

Henderson, Barbara W., Theresa M. Busch, Lurine A. Vaughan, et al.. (2000). Photofrin photodynamic therapy can significantly deplete or preserve oxygenation in human basal cell carcinomas during treatment, depending on fluence rate.. PubMed. 60(3). 525–9. 228 indexed citations

13.

Potter, William R., Barbara W. Henderson, David A. Bellnier, et al.. (1999). Parabolic Quantitative Structure‐Activity Relationships and Photodynamic Therapy: Application of a Three‐Compartment Model with Clearance to the In Vivo Quantitative Structure‐Activity Relationships of a Congeneric Series of Pyropheophorbide Derivatives Used as Photosensitizers for Photodynamic Therapy. Photochemistry and Photobiology. 70(5). 781–788. 4 indexed citations

14.

Potter, William R., Barbara W. Henderson, David A. Bellnier, et al.. (1999). Parabolic Quantitative Structure–Activity Relationships and Photodynamic Therapy: Application of a Three-Compartment Model with Clearance to the In Vivo Quantitative Structure–Activity Relationships of a Congeneric Series of Pyropheophorbide Derivatives Used as Photosensitizers for Photodynamic Therapy. Photochemistry and Photobiology. 70(5). 781–781. 20 indexed citations

15.

Henderson, Barbara W., et al.. (1999). Potentiation of Photodynamic Therapy Antitumor Activity in Mice by Nitric Oxide Synthase Inhibition Is Fluence Rate Dependent. Photochemistry and Photobiology. 70(1). 64–71. 66 indexed citations

16.

17.

Henderson, Barbara W., David A. Bellnier, William R. Greco, et al.. (1997). An in vivo quantitative structure-activity relationship for a congeneric series of pyropheophorbide derivatives as photosensitizers for photodynamic therapy.. PubMed. 57(18). 4000–7. 169 indexed citations

18.

Bellnier, David A., William R. Potter, Lurine A. Vaughan, et al.. (1995). THE VALIDATION OF A NEW VASCULAR DAMAGE ASSAY FOR PHOTODYNAMIC THERAPY AGENTS. Photochemistry and Photobiology. 62(5). 896–905. 27 indexed citations

19.

Mayhew, E., et al.. (1993). LIPID‐ASSOCIATED METHYLPHEOPHORBIDE‐A (HEXYL‐ETHER) AS A PHOTODYNAMIC AGENT IN TUMOR‐BEARING MICE. Photochemistry and Photobiology. 58(6). 845–851. 13 indexed citations

20.

Gessner, Teresa, et al.. (1990). Elevated pentose cycle and glucuronyltransferase in daunorubicin-resistant P388 cells.. PubMed. 50(13). 3921–7. 46 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact